Initial evidence suggests that depressive symptoms are more frequent in patients with atrial fibrillation. Data from the general population are limited.
Methods and Results
In 10,000 individuals (mean age 56±11 years, 49.4% women) of the population-based Gutenberg Health Study we assessed depression by the Patient Health Questionnaire (PHQ-9) and a history of depression in relation to manifest atrial fibrillation (n = 309 cases). The median (25th/75th percentile) PHQ-9 score of depressive symptoms was 4 (2/6) in atrial fibrillation individuals versus 3 (2/6) individuals without atrial fibrillation, . Multivariable regression analyses of the severity of depressive symptoms in relation to atrial fibrillation in cardiovascular risk factor adjusted models revealed a relation of PHQ-9 values and atrial fibrillation (odds ratio (OR) 1.04, 95% confidence interval (CI) 1.01–1.08; P = 0.023). The association was stronger for the somatic symptom dimension of depression (OR 1.08, 95% CI 1.02–1.15; P = 0.0085) than for cognitive symptoms (OR 1.05, 95% CI 0.98–1.11; P = 0.15). Results did not change markedly after additional adjustment for heart failure, partnership status or the inflammatory biomarker C-reactive protein. Both, self-reported physical health status, very good/good versus fair/bad, (OR 0.54, 95% CI 0.41–0.70; P<0.001) and mental health status (OR 0.61 (0.46–0.82); P = 0.0012) were associated with atrial fibrillation in multivariable-adjusted models.
In a population-based sample we observed a higher burden of depressive symptoms driven by somatic symptom dimensions in individuals with atrial fibrillation. Depression was associated with a worse perception of physical or mental health status. Whether screening and treatment of depressive symptoms modulates disease progression and outcome needs to be shown.
Citation: Schnabel RB, Michal M, Wilde S, Wiltink J, Wild PS, Sinning CR, et al. (2013) Depression in Atrial Fibrillation in the General Population. PLoS ONE 8(12): e79109. doi:10.1371/journal.pone.0079109
Editor: Henrik Watz, Pulmonary Research Institute at LungClinic Grosshansdorf, United States of America
Received: July 12, 2013; Accepted: September 25, 2013; Published: December 4, 2013
Copyright: © 2013 Schnabel et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The Gutenberg Health Study is funded through the government of Rheinland-Pfalz (“Stiftung Rheinland Pfalz für Innovation”, contract number AZ 961-386261/733), the research programs “Wissen schafft Zukunft” and “Schwerpunkt Vaskuläre Prävention” of the Johannes Gutenberg-University of Mainz and its contract with Boehringer Ingelheim and PHILIPS Medical Systems including an unrestricted grant for the Gutenberg Health Study. Dr. Schnabel is supported by Deutsche Forschungsgemeinschaft (German Research Foundation) Emmy Noether Program SCHN 1149/3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors received funding (unrestricted grant) from commercial sources “Boehringer Ingelheim” and “PHILIPS Medical Systems”. Also, co-author Renate B. Schnabel is a PLOS ONE Editorial Board member. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Atrial fibrillation (AF) and its sequelae have become a significant public health burden and cost factor in the health care system due to an increasing prevalence in aging populations . Although individuals with AF are at high risk of incident stroke and heart failure, an increased risk of death remains after accounting for these serious complications and other cardiovascular comorbidities. Numerous studies have found that depression predicts prognosis in cardiac conditions such as stable coronary artery disease, myocardial infarction, and heart failure . Evidence suggests that depressive symptoms in AF are related to the recurrence of AF episodes  and the occurrence of complications of AF such as heart failure and death in the clinical setting . From other cardiovascular diseases we know that psychosocial distress may influence hemodynamics, vascular function, autonomic tone, inflammatory activity, and hemostasis , , , all of which play a role in the pathogenesis and complications of AF.
Initial smaller investigations in AF indicate that the disease is frequently accompanied by depressive symptoms which may impact physical activity and quality of life in AF patients , , . However, overall there is a critical lack of knowledge regarding the type and extent of psychological distress and its consequences in patients diagnosed with AF . Data in individuals with AF in the general population are rare. We hypothesized that in ambulatory individuals from the general population depression is more frequent in AF independent of age, sex and cardiovascular comorbidities.
Prior to enrolment participants signed written, informed consent. The study has been approved by the local Ethics Committee (Landesaerztekammer Rheinland-Pfalz, 837.020.07).
The Gutenberg Health Study constitutes a cohort of a randomly selected population-based sample of the region of Mainz/Mainz-Bingen aged 35 to 74 years with a proportion of 49% women. It was incepted in 2007 at the Department of Medicine 2, University Medical Center Mainz. During the baseline clinic visit comprehensive information on cardiovascular risk factors is collected by anthropometric measures and standardized computer-assisted interview. Classical cardiovascular risk factors were defined as follows: Smoking status comprised the categories non-smokers (never smokers and former smokers) and smokers. Diabetes mellitus was diagnosed when individuals reported a physician diagnosis of diabetes and/or a fasting blood glucose concentration of ≥126 mg/dL (minimum 8-hour fast) or a blood glucose level of ≥200 mg/dL at any time was measured on site. Dyslipidemia was defined based on a physician's diagnosis of dyslipidemia and/or a low-density-lipoprotein/high-density-lipoprotein cholesterol ratio of >3.5. The definition of hypertension comprised anti-hypertensive drug treatment and/or a mean systolic blood pressure of ≥140 mmHg and/or a mean diastolic blood pressure of ≥90 mmHg.
Myocardial infarction was assessed by self-report. Heart failure was defined by self-reported treatment of heart failure within the last 12 months.
Depression was assessed by the Patient Health Questionnaire (PHQ-9), which quantifies the frequency of being bothered by each of the 9 diagnostic criteria of Major Depression over the past 2 weeks. Responses are summed to create a score between 0 and 27 points. A PHQ-9 sum score of ≥10 was used for the definition of caseness for depression . The somatic and cognitive dimensions of depression were defined according to prior studies , , , , . Four PHQ-9 items related to problems with sleep, fatigability, appetite, and psychomotor agitation/retardation were classified as somatic depressive symptoms, whereas 5 items, related to lack of interest, depressed mood, negative feelings about self, concentration problems and suicidal ideation, were classified as cognitive depressive symptoms. During the computer-assisted personal interview participants were asked whether they had ever received the definite diagnosis of any depressive disorder by a physician (medical history of lifetime diagnosis of any depressive disorder).
Socioeconomic status was evaluated using Lampert's and Kroll's Score of socioeconomic status that ranges from 3 to 27 with 3 indicating the lowest socioeconomic status.
The diagnosis of AF was made based on a history of AF reported by the participant and/or the electrocardiographic documentation (GE Cardiosoft®) of AF or atrial flutter . At least two physicians with cardiology training and experience in electrocardiogram (ECG) reading had to agree on the diagnosis.
C-reactive protein (CRP) was measured from fasting blood samples by a standardized method through particle enhanced turbidimetric immunoassay (Dimension® Chemistry System, Dade Behring).
All authors have read and approved the manuscript as written.
Data were analyzed for the first 10,000 consecutive GHS individuals. We did not require complete case analysis so that in some analyses the total number of individuals may be smaller than the total sample size. Demographics and prevalence of risk factors for the study sample weighted for the population of the region Mainz/Mainz-Bingen are also provided in the supplement. Since depression may depend on awareness of the disease AF, we also present data separately for individuals with a prior diagnosis of AF and participants with a first diagnosis of AF on the study ECG. In logistic regression models, depression and its dimensions were related to atrial fibrillation. Models were adjusted for age and sex as well as for age, sex and atrial fibrillation risk factors body mass index, systolic blood pressure, antihypertensive medication, diabetes, current smoking, dyslipidemia and a family history of myocardial infarction. Model R2 values were calculated. Additional models were calculated adjusting for heart failure, partnership status or CRP. We tested for interactions of depressive symptoms in association with AF by age and sex.
To understand whether depression and its symptom dimensions are mediated by other psychosocial conditions, cardiac function or inflammatory activity, we describe depressive symptoms according to partnership, manifest heart failure, and median CRP concentrations. Due to expectedly lower numbers in the subgroup of individuals with AF we performed analyses for very good/good versus fair/bad self-rated physical and mental health status.
In secondary analyses we also performed multivariable regression analyses of depressive symptom dimensions in relation to self-rated physical and mental health status for individuals with AF.
We assumed a threshold of P<0.05 for statistical significance. As this is an explorative study no adjustments for multiple testing have been performed. P values are given for descriptive reasons.
Statistical calculations were performed using R software, Version 2.14.0 (R Development Core Team, 2009). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, http://www.r-project.org/)
The study sample by AF status is described in Table 1. Individuals with AF were older (mean±standard deviation (SD)) 64.8±8.2 versus 55.2±10.8 years in individuals without AF, less than one third was female. Except for smoking cardiovascular risk factors were more frequent in AF. CRP concentrations were higher 3.6±4.1 mg/L than in individuals without a diagnosis of AF 2.9±5.5 mg/L. A history of depression was documented in 16.2% of AF individuals. The median (25th/75th percentile) PHQ-9 value was 4 (2/6) compared to 3 (2/6) participants without AF. Of individuals with AF 34.9% reported impaired physical health, 21.4% reduced mental health compared to 20.3% and 17.2%, respectively, in the rest of the sample. Data weighted for the total population were comparable as shown in Table S1. Variable distribution was similar in individuals with a history of AF and newly diagnosed AF (Table S2).
Multivariable regression analyses of depressive symptom dimensions in relation to AF in cardiovascular risk factor adjusted models (Table 2) showed an association of the degree of depressive symptoms (PHQ-9 sum score, range 0–27) and AF (odds ratio (OR) 1.04, 95% confidence interval (CI) 1.01–1.08; P = 0.023). The association was more pronounced for the somatic symptom dimension of depression, OR 1.08, 95% CI 1.02–1.15; P = 0.0085 than for cognitive depressive symptoms, OR 1.05, 95% CI 0.98–1.11; P = 0.15.
Worse self-reported physical health status was also associated with AF, OR 0.54, 95% CI 0.41–0.70; P<0.0001; as well as worse mental health status (OR 0.61 (0.46–0.82); P = 0.0012. Model R2 values were 0.16 for both. We did not identify statistically significant interactions of association between depressive symptom dimensions and AF.
Direction and magnitude of association results were similar when we restricted analyses to individuals with known AF (Table S3). Results were not markedly changed when multivariable-adjustment also incorporated heart failure, partnership status or CRP concentrations (data not shown).
In Table 3, 4 and 5 variables of depressive symptoms, health status, and socioeconomic status are demonstrated by a diagnosis of heart failure, partnership status and median CRP concentrations. None of the somatic and cognitive depressive symptoms appeared to be different in the subgroups. Self-reported very good and good mental health status reached borderline significance with lower frequency in AF individuals with heart failure (64.9% versus 80.5% in individuals without heart failure; ). Very good and good physical health were also seen less frequently in individuals with AF (45.9% versus 67.6% in individuals without AF; ) (Table 3). Socioeconomic status was higher in individuals with a regular partnership and lower CRP concentrations, P<0.001 (Table 4 and 5).
In regression analyses, somatic as well as cognitive depressive symptoms were inversely related to self-reported physical and mental health status in individuals with AF in multivariable-adjusted models for a history of depression, severity of depressive symptoms assessed by PHQ-9 as well as for caseness of depression (Table S4).
In our large population-based sample, we could demonstrate a slightly higher burden of depressive symptoms in individuals with AF driven by somatic symptom dimensions independent of age, sex and classical cardiovascular risk factors. Prevalent heart failure, partnership status, or low-grade inflammation did not seem to account for depressive symptom dimensions to a relevant degree. Both, self-reported physical health status and mental health status were lower in AF individuals and were related to depressive symptom severity.
In our sample we demonstrated that a physician-diagnosed history of depression and current depressive symptoms were slightly more frequent in participants with AF compared to individuals without documented AF. The Somatic symptom dimension of depression accounted for most of the observed associations similar to other cardiovascular diseases , , . Mostly behavioural mediators, such as reduced physical activity, unhealthy lifestyle and poor treatment adherence have been made responsible for cardiovascular disease progression and adverse prognosis in patients with depressive symptoms . Disease related physical impairment may also aggravate depressive symptoms and negative health behaviours. A small study in community-dwelling elderly patients reported poorer physical health-related quality of life in AF . We found a comparable magnitude of the association of self-reported impaired physical and mental health in participants with AF in our sample. To further elucidate the role of self-reported reduced physical health in AF, we examined heart failure as a potential underlying cause of physical impairment. Heart failure is a common comorbid condition in AF individuals , and may significantly affect physical symptom status. Depression is frequent in heart failure patients and it carries a risk factor for adverse outcome . Neither somatic nor cognitive depressive symptom dimensions differed significantly depending on presence of heart failure. In contrast, physical as well as mental health status were rated lower in the subgroup of individuals with manifest heart failure. When main regression analyses were adjusted for prevalent heart failure, results remained stable indicating that heart failure did not account for depressive symptoms to a large extent despite an association with physical and mental health.
In AF patients psychological distress may drive AF-specific symptom severity and healthcare resource utilization independent of AF burden , . To understand whether the awareness of the diagnosis of AF is related to more severe depressive symptoms we performed subgroup analyses in individuals with a self-reported history of AF. Results were comparable to the main analyses after exclusion of individuals who have not been aware of their disease. This observation renders it unlikely that depression is only an emotional consequence of labeling oneself as a cardiac case.
Whether depressive symptom dimensions in atrial fibrillation individuals are mediated through elevated inflammatory activity was assessed by CRP measurement. Inflammatory pathways underlie both conditions, AF  and depression . Elevated inflammatory activity in depression has been made responsible for adverse outcomes in patients with manifest cardiovascular disease . In a small study in AF patients, type D personality, i.e. the compound of negative affectivity and social inhibition, and CRP were related to health related quality of life . In our analyses, we did not observe significant differences for associations of depressive symptom dimensions with higher CRP concentrations or after adjustment for circulating CRP. Thus it seems that correlations are not primarily driven by inflammation despite a potential common background of both disease states.
As a previous study found that elevated depression symptoms and marital status had an additive predictive value for cardiovascular and arrhythmic death , we analyzed whether the association of AF with depression was mediated through living in a partnership. Indeed, a history of depression and self rated poor mental health status were more prominent among persons with AF living without a current partnership. Thus, lack of social support respectively living without a partner might moderate the association of depression with AF.
Our findings are in line with recent publications. For several common diseases it could be demonstrated that concomitant depression is related to worse overall health rating than the disease alone . The obvious goal of improving mental well-being in AF needs to be examined for its efficiency with respect to quality of life and healthcare costs.
We did not observe significant interactions by age or sex. Whereas age seems to play a minor role for the prevalence of depression, female sex is a strong risk factor for depressive symptoms , . The number of women with AF in our sample, however, was comparatively small and statistical significance may not have been reached.
The current study results will have potential public health impact for AF. In health professionals, awareness of depression and mental health status in atrial fibrillation needs to increase. Systematic screening may enhance our understanding of prevalence and sequelae of depression in AF. The identification of depression is important because it impairs subjective mental and physical health status in AF. Such symptoms can be positively affected by lifestyle interventions, psychotherapy, and medication , . Changes in depressive symptoms could lead to better quality of life, and might affect outcome in AF individuals in the general population. Importantly, proper treatment and prevention of AF recurrence has the potential to significantly reduce depressive symptoms and finally, reduce healthcare costs .
Characteristics of the sample by AF status weighted for population of the geographic region.
Characteristics of participants with a diagnosis of AF stratified by awareness of atrial fibrillation.
Multivariable logistic regression of depressive symptom dimensions in relation to AF for individuals with a self-reported history of AF (N = 265).
Multivariable logistic regression of depressive symptom dimensions in relation to self-rated physical well-being (A) and mental well-being (B) for individuals with AF (N = 309).
We thank the participants and dedicated study staff of the Gutenberg Health Study for their generous contribution of time and efforts.
Conceived and designed the experiments: RBS MM SW PSW TZ SB MB TM. Performed the experiments: RBS SW PSW. Analyzed the data: RBS SW FMO. Wrote the paper: RBS MM SW FMO. Results discussion and critical review: JW CRS EL.
- 1. Holstenson E, Ringborg A, Lindgren P, Coste F, Diamand F, et al. (2011) Predictors of costs related to cardiovascular disease among patients with atrial fibrillation in five European countries. Europace 13: 23–30. doi: 10.1093/europace/euq325
- 2. Vaccarino V, Johnson BD, Sheps DS, Reis SE, Kelsey SF, et al. (2007) Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study. J Am Coll Cardiol 50: 2044–2050. doi: 10.1016/j.jacc.2007.07.069
- 3. Lange HW, Herrmann-Lingen C (2007) Depressive symptoms predict recurrence of atrial fibrillation after cardioversion. J Psychosom Res 63: 509–513. doi: 10.1016/j.jpsychores.2007.07.010
- 4. Frasure-Smith N, Lesperance F, Habra M, Talajic M, Khairy P, et al. (2009) Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure. Circulation 120: 134–3, 134-40, 3. doi: 10.1161/circulationaha.109.851675
- 5. Jones A, Steeden JA, Pruessner JC, Deanfield JE, Taylor AM, et al. (2011) Detailed assessment of the hemodynamic response to psychosocial stress using real-time MRI. J Magn Reson Imaging 33: 448–454. doi: 10.1002/jmri.22438
- 6. Carney RM, Freedland KE, Veith RC, Cryer PE, Skala JA, et al. (1999) Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease. Biol Psychiatry 45: 458–463. doi: 10.1016/s0006-3223(98)00049-3
- 7. Whooley MA, de JP, Vittinghoff E, Otte C, Moos R, et al. (2008) Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 300: 2379–2388. doi: 10.1001/jama.2008.711
- 8. Thrall G, Lip GY, Carroll D, Lane D (2007) Depression, anxiety, and quality of life in patients with atrial fibrillation. Chest 132: 1259–1264. doi: 10.1378/chest.07-0036
- 9. Dorian P, Jung W, Newman D, Paquette M, Wood K, et al. (2000) The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol 36: 1303–1309. doi: 10.1016/s0735-1097(00)00886-x
- 10. McCabe PJ (2010) Psychological distress in patients diagnosed with atrial fibrillation: the state of the science. J Cardiovasc Nurs 25: 40–51. doi: 10.1097/jcn.0b013e3181b7be36
- 11. Lowe B, Grafe K, Zipfel S, Witte S, Loerch B, et al. (2004) Diagnosing ICD-10 depressive episodes: superior criterion validity of the Patient Health Questionnaire. Psychother Psychosom 73: 386–390. doi: 10.1159/000080393
- 12. Smolderen KG, Spertus JA, Reid KJ, Buchanan DM, Krumholz HM, et al. (2009) The association of cognitive and somatic depressive symptoms with depression recognition and outcomes after myocardial infarction. Circ Cardiovasc Qual Outcomes 2: 328–337. doi: 10.1161/circoutcomes.109.868588
- 13. Hoen PW, Whooley MA, Martens EJ, Na B, van Melle JP, et al. (2010) Differential associations between specific depressive symptoms and cardiovascular prognosis in patients with stable coronary heart disease. J Am Coll Cardiol 56: 838–844. doi: 10.1016/j.jacc.2010.03.080
- 14. De Jonge P, Mangano D, Whooley MA (2007) Differential association of cognitive and somatic depressive symptoms with heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study. Psychosom Med 69: 735–739. doi: 10.1097/psy.0b013e31815743ca
- 15. Michal M, Wiltink J, Kirschner Y, Wild PS, Munzel T, et al. (2013) Differential associations of depressive symptom dimensions with cardio-vascular disease in the community: results from the gutenberg health study. PLoS ONE 8: e72014. doi: 10.1371/journal.pone.0072014
- 16. Michal M, Wiltink J, Lackner K, Wild PS, Zwiener I, et al. (2013) Association of hypertension with depression in the community: results from the Gutenberg Health Study. J Hypertens 31: 893–899. doi: 10.1097/hjh.0b013e32835f5768
- 17. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, et al. (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31: 2369–2429. doi: 10.1093/eurheartj/ehq512
- 18. Martens EJ, Hoen PW, Mittelhaeuser M, de JP, Denollet J (2010) Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis. Psychol Med 40: 807–814. doi: 10.1017/s0033291709990997
- 19. Ormel J, de JP (2011) Unipolar depression and the progression of coronary artery disease: toward an integrative model. Psychother Psychosom 80: 264–274. doi: 10.1159/000323165
- 20. Ariansen I, Dammen T, Abdelnoor M, Tveit A, Gjesdal K (2011) Mental health and sleep in permanent atrial fibrillation patients from the general population. Clin Cardiol 34: 327–331. doi: 10.1002/clc.20883
- 21. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, et al. (2003) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107: 2920–2925. doi: 10.1161/01.cir.0000072767.89944.6e
- 22. Jiang W, Alexander J, Christopher E, Kuchibhatla M, Gaulden LH, et al. (2001) Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 161: 1849–1856. doi: 10.1001/archinte.161.15.1849
- 23. Gehi AK, Sears S, Goli N, Walker TJ, Chung E, et al. (2012) Psychopathology and symptoms of atrial fibrillation: implications for therapy. J Cardiovasc Electrophysiol 23: 473–478. doi: 10.1111/j.1540-8167.2011.02264.x
- 24. Sears SF, Serber ER, Alvarez LG, Schwartzman DS, Hoyt RH, et al. (2005) Understanding atrial symptom reports: objective versus subjective predictors. Pacing Clin Electrophysiol 28: 801–807. doi: 10.1111/j.1540-8159.2005.00171.x
- 25. Schnabel RB, Larson MG, Yamamoto JF, Kathiresan S, Rong J, et al. (2009) Relation of multiple inflammatory biomarkers to incident atrial fibrillation. Am J Cardiol 104: 92–96. doi: 10.1016/j.amjcard.2009.02.053
- 26. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, et al. (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67: 446–457. doi: 10.1016/j.biopsych.2009.09.033
- 27. Frasure-Smith N, Lesperance F, Irwin MR, Sauve C, Lesperance J, et al. (2007) Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes. Biol Psychiatry 62: 302–308. doi: 10.1016/j.biopsych.2006.09.029
- 28. Son YJ, Song EK (2012) The impact of type D personality and high-sensitivity C-reactive protein on health-related quality of life in patients with atrial fibrillation. Eur J Cardiovasc Nurs 11: 304–312.
- 29. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, et al. (2007) Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370: 851–858. doi: 10.1016/s0140-6736(07)61415-9
- 30. Katon W (2012) Collaborative depression care models: from development to dissemination. Am J Prev Med 42: 550–552. doi: 10.1016/j.amepre.2012.01.017
- 31. Blumenthal JA, Babyak MA, O'Connor C, Keteyian S, Landzberg J, et al. (2012) Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial. JAMA 308: 465–474. doi: 10.1001/jama.2012.8720
- 32. Sang CH, Chen K, Pang XF, Dong JZ, Du X, et al. (2013) Depression, anxiety, and quality of life after catheter ablation in patients with paroxysmal atrial fibrillation. Clin Cardiol 36: 40–45. doi: 10.1002/clc.22039